当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析

上海医药

(601607)

  

流通市值:500.10亿  总市值:664.91亿
流通股本:27.89亿   总股本:37.08亿

上海医药(601607)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润59.86亿元,每股收益1.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益8962262.38万元,未分配利润4060314.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产23674624.52万元,负债14712362.14万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入215,072,230,363.46141,592,782,502.7970,762,515,910.94275,250,934,889.66
营业总成本209,405,979,454.06137,611,880,810.1968,666,635,360.52267,676,306,689.98
其他经营收益
营业利润8,336,769,468.256,833,619,624.552,146,390,114.158,140,712,946.17
利润总额8,298,097,112.996,820,820,702.732,152,717,007.538,020,006,543.74
净利润5,986,149,437.794,994,784,030.291,640,193,471.65,870,011,314.88
每股收益
其他综合收益14,170,692.5319,680,758.31-3,441,851.94-62,617,948.59
综合收益总额6,000,320,130.325,014,464,788.61,636,751,619.665,807,393,366.29
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计183,928,273,389.51184,456,754,035.33177,311,702,074.79171,823,107,421.97
非流动资产:
非流动资产合计52,817,971,846.7153,610,302,036.0448,560,189,615.0249,386,322,726.2
资产总计236,746,245,236.22238,067,056,071.37225,871,891,689.81221,209,430,148.17
流动负债:
流动负债合计138,990,247,902.67140,131,022,109.65130,813,134,867.82126,038,386,279.1
非流动负债:
非流动负债合计8,133,373,495.449,078,129,398.079,757,787,539.4211,428,680,148
负债合计147,123,621,398.11149,209,151,507.72140,570,922,407.24137,467,066,427.1
所有者权益(或股东权益):
归属于母公司股东权益合计75,782,860,404.6275,095,652,523.3373,010,725,504.8671,675,619,971.97
股东权益合计89,622,623,838.1188,857,904,563.6585,300,969,282.5783,742,363,721.07
负债和股东权益合计236,746,245,236.22238,067,056,071.37225,871,891,689.81221,209,430,148.17
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计227,469,442,376.77151,090,834,889.9372,342,373,807.62304,650,625,623.94
经营活动现金流出小计225,119,632,211.18150,101,577,901.0474,546,689,410.83298,823,367,892.61
经营活动产生的现金流量净额2,349,810,165.59989,256,988.89-2,204,315,603.215,827,257,731.33
投资活动产生的现金流量:
投资活动现金流入小计52,808,923,072.5437,691,184,962.9416,458,582,841.150,433,234,630.15
投资活动现金流出小计53,599,231,026.2538,931,450,587.817,431,520,246.1150,017,254,930.46
投资活动产生的现金流量净额-790,307,953.71-1,240,265,624.86-972,937,405.01415,979,699.69
筹资活动产生的现金流量:
筹资活动现金流入小计56,293,170,086.6541,955,523,827.7823,252,698,353.1874,149,022,397.97
筹资活动现金流出小计56,846,805,091.9138,202,146,690.0219,388,489,487.1976,012,952,776.63
筹资活动产生的现金流量净额-553,635,005.263,753,377,137.763,864,208,865.99-1,863,930,378.66
汇率变动对现金及现金等价物的影响-11,454,659.07-13,772,678.984,038,703.532,156,741.31
现金及现金等价物净增加额994,412,547.553,488,595,822.81690,994,561.34,381,463,793.67
期末现金及现金等价物余额32,875,685,342.4235,369,868,617.6832,572,267,356.1731,881,272,794.87
补充资料:
现金及现金等价物的净增加额-3,488,595,822.81-4,381,463,793.67
最新报告期:2025-11-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘若飞,贺菊颖1.591.401.532025-11-11
平安证券叶寅,倪亦道,王钰畅1.401.531.612025-11-03
中金公司夏璐,张琎,朱言音1.341.45--2025-11-01
中信建投刘若飞,贺菊颖1.691.331.452025-09-05
中邮证券龙永茂1.541.491.642025-09-05
TOP↑